Enhancement of aerosol cisplatin chemotherapy with gene therapy expressing ABC10 protein in respiratory system

Journal of Cancer

Volumn 5, Issue 5, 2014, Pages 344-350

  Hohenforst Schmidt, Wolfgang ^a   Zarogoulidis, Paul ^b   Linsmeier, Bernd ^c   Kioumis, Ioannis ^b   Li, Qiang ^d   Huang, Haidong ^d   Sachpatzidou, Despoina ^e   Lampaki, Sofia ^b   Organtzis, John ^b   Domvri, Kalliopi ^b   Sakkas, Leonidas ^f   Zachariadis, George A ^a   Archontas, Konstantinos N ^a   Kallianos, Anastasios ^g   Rapti, Aggeliki ^g   Yarmus, Lonny ^h   Zarogoulidis, Konstantinos ^b   Brachmann, Johannes ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MEDINOS Clinic   (Germany)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Experimental Animal Laboratory 'Theiagenio' Anticancer Hospital   (Greece)

^f G PAPANICOLAOU HOSPITAL   (Greece)

^g SOTIRIA GENERAL HOSPITAL   (Greece)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ABC10; Aerosol; ATP; Chemotherapy; Gene therapy; Lung cancer

Indexed keywords

ABC 10 PROTEIN; ABC TRANSPORTER; ADENOVIRUS VECTOR; CISPLATIN; HOSPIRA; PLATINUM; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; GENE THERAPY; LONG TERM SURVIVAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RESPIRATORY SYSTEM; TUMOR VOLUME;

EID: 84897011100     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.9021     Document Type: Article

References (48)

1. Heavey S, O'Byrne KJ, Gately K. Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC. Cancer Treat Rev. 2013.
2. Notsuda H, Sakurada A, Endo C, et al. p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells. Int J Oncol. 2013;43(5):1569-1577.
3. Shimamura T, Chen Z, Soucheray M, et al. Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer. Clin Cancer Res. 2013.
4. Zarogoulidis K, Papagiannis A, Ziogas E, et al. Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer. Eur J Cancer. 1997;33(14):2428-2431.
5. Mayordomo JI, Lopez A, Vinolas N, et al. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. Curr Med Res Opin. 2009;25(10):2533-2542.
6. Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, et al. Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. Drug Des Devel Ther. 2013;7:571-583.
7. Baliaka A, Zarogoulidis P, Domvri K, et al. Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-Diethylaminoethyl-Dextran Methyl Methacrylate Copolymer Non-Viral Vector-p53. Gene Ther. 2013.
8. Simoglou C, Zarogoulidis P, Machairiotis N, et al. Abdominal wall endometrioma mimicking an incarcerated hernia: a case report. Int J Gen Med. 2012;5:569-571.
9. Zarogoulidis P, Darwiche K, Krauss L, et al. Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients. Future Oncol. 2013;9(9):1307-1313.
10. Zarogoulidis P, Chatzaki E, Porpodis K, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine. 2012;7:1551-1572.
11. Zarogoulidis P, Chatzaki E, Hohenforst-Schmidt W, et al. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Cancer Gene Ther. 2012;19(9):593-600.
12. Zarogoulidis P, Darwiche K, Hohenforst-Schmidt W, et al. Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer. Future Oncol. 2013;9(8):1171-1194.
13. Zarogoulidis P, Zarampouka K, Huang H, et al. Hedgehog signaling pathway: the must, the maybe and the unknown. J Thorac Dis. 2013;5(2):195-197.
14. Domvri K, Zarogoulidis P, Darwiche K, et al. Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer. 2013;4(9):736-754.
15. Kwon I, Schaffer DV. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res. 2008;25(3):489-499.
16. Koshkina NV, Kleinerman ES. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer. 2005;116(3):458-463.
17. Lemarie E, Vecellio L, Hureaux J, et al. Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. J Aerosol Med Pulm Drug Deliv. 2011;24(6):261-270.
18. Gautam A, Koshkina N. Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery. Curr Cancer Drug Targets. 2003;3(4):287-296.
19. Otterson GA, Villalona-Calero MA, Sharma S, et al. Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res. 2007;13(4):1246-1252.
20. Otterson GA, Villalona-Calero MA, Hicks W, et al. Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin Cancer Res. 2010;16(8):2466-2473.
21. Tatsumura T, Koyama S, Tsujimoto M, Kitagawa M, Kagamimori S. Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br J Cancer. 1993;68(6):1146-1149.
22. Karnezis TT, Davidson TM. Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis. Laryngoscope. 2011;121(3):636-638.
23. Camus P. Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management. Br J Cancer. 2004;91 Suppl 2:S1-2.
24. Stenmark MH, Cai XW, Shedden K, et al. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84(2):e217-222.
25. Zarogoulidis P, Petridis D, Ritzoulis C, et al. Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics. Int J Pharm. 2013;456(2):325-331.
26. Bae YH. Interview with Dr You Han Bae: ligand-mediated versus 'passive' targeting approaches in nanoparticle oncology research. Ther Deliv. 2012;3(8):933-936.
27. Tseng CL, Su WY, Yen KC, Yang KC, Lin FH. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials. 2009;30(20):3476-3485.
28. Bosquillon C. Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci. 2010;99(5):2240-2255.
29. Zarogoulidis P, Darwiche K, Spyratos D, et al. Defense Mechanisms of the Respiratory System and Aerosol Production Systems. Med Chem. 2013.
30. Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv. 2004;1(1):27-42.
31. Ueda K. ABC proteins protect the human body and maintain optimal health. Biosci Biotechnol Biochem. 2011;75(3):401-409.
32. Horio M, Gottesman MM, Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci U S A. 1988;85(10):3580-3584.
33. Bertram JS, Janik P. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett. 1980;11(1):63-73.
34. Zarogoulidis P, Hohenforst-Schmidt W, Darwiche K, et al. 2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy. Gene Ther. 2013;20(10):1022-1028.
35. Zarogoulidis P, Petridis D, Ritzoulis C, et al. Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays' production systems. Int J Pharm. 2013;458(1):39-47.
36. Zarogoulidis P, Porpodis K, Kioumis I, et al. Experimentation with Inhaled Bronchodilators and Corticosteroids. Int J Pharm. 2013.
37. Zarogoulidis P, Papanas N, Kouliatsis G, Spyratos D, Zarogoulidis K, Maltezos E. Inhaled insulin: too soon to be forgotten? J Aerosol Med Pulm Drug Deliv. 2011;24(5):213-223.
38. Salloum RG, Smith TJ, Jensen GA, Lafata JE. Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Lung Cancer. 2012;75(2):255-260.
39. Darwiche K, Zarogoulidis P, Karamanos NK, et al. Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology. Future Oncol. 2013;9(4):505-525.
40. Porpodis K, Karanikas M, Zarogoulidis P, et al. A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy. J Multidiscip Healthc. 2012;5:47-51.
41. Xie Y, Aillon KL, Cai S, et al. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. Int J Pharm. 2010;392(1-2):156-163.
42. Akkas BE, Gokcora N, Atasever T, Yetkin I. The use of technetium-99m hexamethylpropylene amine oxime lung scintigraphy in the detection of subclinical lung injury in patients with noninsulin-dependent diabetes mellitus. Nucl Med Commun. 2011;32(12):1179-1184.
43. Zarogoulidis P, Eleftheriadou E, Sapardanis I, et al. Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest New Drugs. 2012;30(4):1628-1640.
44. Ohtsuki S, Kamoi M, Watanabe Y, Suzuki H, Hori S, Terasaki T. Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor. Biol Pharm Bull. 2007;30(6):1144-1146.
45. Takenaka S, Itoh T, Fujiwara R. Expression pattern of human ATP-binding cassette transporters in skin. Pharmacology research and perspectives. 2013;:1-8.
46. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11(7):1156-1166.
47. Liu Y, Peng H, Zhang JT. Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray. Mol Pharmacol. 2005;68(2):430-438.
48. Pohl A, Devaux PF, Herrmann A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim Biophys Acta. 2005;1733(1):29-52.